An AFB-DNA (TB-PCR) Detection by Real-Time PCR with Reflex to Rifampicin Resistance by Ultra CBNAAT on Sputum is a premier, ultra-sensitive molecular test for diagnosing Pulmonary Tuberculosis (TB).

While traditional microscopic smears look for the physical bacterium under a lens, this advanced panel directly extracts and copies the genetic blueprint (DNA) of the Mycobacterium tuberculosis complex. It stands as a vital frontline diagnostic tool because it rapidly answers two clinical questions directly from a sputum sample: Is the patient infected with TB? and if so, Will standard first-line antibiotics work against it?

Deconstructing the Test Terminology
AFB-DNA (TB-PCR) by RTPCR: The laboratory uses Real-Time Polymerase Chain Reaction to replicate specific genetic sequences unique to TB. Because it amplifies target DNA millions of times, it can detect the presence of the bacteria even if the patient has a very low bacterial load (paucibacillary sputum), which a standard microscope smear would completely miss.

Reflex to Ultra CBNAAT: "Reflexing" means the laboratory automation software automatically launches a secondary, deeper test only if the initial PCR screen detects TB DNA. The patient does not need to return to give a second sample.

Ultra CBNAAT (Cartridge-Based Nucleic Acid Amplification Test): This refers specifically to the newer GeneXpert MTB/RIF Ultra technology. The "Ultra" cartridge features an increased sample chamber volume and nested PCR technology, providing unmatched sensitivity.

Rifampicin Resistance: Rifampicin is a cornerstone drug in standard anti-tubercular therapy. The Ultra assay maps the bacterial rpoB gene to check for mutations that make the bacteria immune to Rifampicin. Resistance to this drug is a critical marker for Multidrug-Resistant Tuberculosis (MDR-TB).

An **AFB (Acid-Fast Bacilli) Detection of DNA by Real-Time PCR (Tissue/Biopsy)** is a highly precise molecular diagnostic test used to rapidly identify *Mycobacterium tuberculosis* complex (MTBC) and other mycobacteria directly from tissue specimens or biopsy samples.

Unlike traditional cultures that require weeks for bacteria to grow, this test looks for the genetic blueprint (DNA) of the bacteria, offering highly accurate results in just a matter of hours.

---

### How the Test Works

* **The Target:** The test utilizes **Real-Time Polymerase Chain Reaction (PCR)** technology to detect specific, highly conserved DNA sequences unique to mycobacteria (such as the *IS6110* or *senX3-regX3* genetic markers for *M. tuberculosis*).
* **Amplification:** The laboratory extracts DNA from the biopsy sample (e.g., lymph node, skin, or bone tissue). If even a tiny fragment of target bacterial DNA is present, the PCR machine replicates it millions of times.
* **Real-Time Monitoring:** Fluorescent dyes attach to the DNA copies as they are being made. A computer monitors this fluorescence in real-time; if the signal crosses a specific threshold, the test is confirmed positive.

---

### Key Advantages of This Test

* **Exceptional Speed:** While an automated MGIT liquid culture takes 1 to 3 weeks to flag a positive result, Real-Time PCR can deliver definitive answers within **24 to 48 hours**.
* **High Sensitivity:** It can detect minute amounts of bacterial DNA, making it incredibly useful for "paucibacillary" samples—tissue biopsies where the number of actual bacterial cells is very low.
* **Detects Dead Bacteria:** Because it looks for DNA rather than live organisms, it can still detect the infection even if the patient has already started taking anti-TB medications.
* **Drug Resistance Detection (Reflex):** Many modern Real-Time PCR assays (like GeneXpert or custom multiplex panels) don't just detect the DNA—they simultaneously check for mutations in genes like *rpoB*, immediately alerting doctors if the strain is resistant to major frontline antibiotics like Rifampicin.